Lanean...
Dapagliflozin in patients with type 2 diabetes mellitus
Dapagliflozin is a selective and reversible inhibitor of sodium–glucose linked transporter type 2 (SGLT2), which mediates approximately 90% of active renal glucose reabsorption in the early proximal tubule of the kidney. Dapagliflozin significantly reduces glucose reabsorption and decreases serum gl...
Gorde:
| Argitaratua izan da: | Ther Adv Endocrinol Metab |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4321869/ https://ncbi.nlm.nih.gov/pubmed/25678954 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018814558243 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|